INNOVATE Corp. Files 8-K Report
Ticker: VATE · Form: 8-K · Filed: Mar 25, 2024 · CIK: 1006837
| Field | Detail |
|---|---|
| Company | Innovate Corp. (VATE) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $19.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
TL;DR
INNOVATE Corp. filed an 8-K, likely with updated financials and other disclosures.
AI Summary
On March 25, 2024, INNOVATE Corp. (formerly HC2 Holdings, Inc.) filed an 8-K report. The filing primarily serves as a notification of other events and the inclusion of financial statements and exhibits. No specific material events or financial figures were detailed in the provided excerpt.
Why It Matters
This filing indicates that INNOVATE Corp. is providing updated information to the SEC, which could include material disclosures relevant to investors.
Risk Assessment
Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific material events or financial data that would indicate a change in risk.
Key Players & Entities
- INNOVATE Corp. (company) — Registrant
- HC2 Holdings, Inc. (company) — Former company name
- March 25, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing for INNOVATE Corp.?
The primary purpose of this 8-K filing is to report 'Other Events' and to include 'Financial Statements and Exhibits' as of March 25, 2024.
What was INNOVATE Corp.'s former name?
INNOVATE Corp.'s former name was HC2 Holdings, Inc.
On what date was this 8-K report filed?
This 8-K report was filed on March 25, 2024.
In which state is INNOVATE Corp. incorporated?
INNOVATE Corp. is incorporated in Delaware.
What is the business address of INNOVATE Corp. as listed in the filing?
The business address listed is 295 Madison Ave, 12th Floor, New York, NY 10017.
Filing Stats: 825 words · 3 min read · ~3 pages · Grade level 11.3 · Accepted 2024-03-25 16:45:49
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share VATE New York Stock Exchange
- $19.0 million — ration date of its previously announced $19.0 million common stock rights offering (the "Righ
Filing Documents
- hchc-20240325.htm (8-K) — 35KB
- a202403258-kxexh991.htm (EX-99.1) — 7KB
- innovateforproxy.jpg (GRAPHIC) — 17KB
- 0001006837-24-000034.txt ( ) — 239KB
- hchc-20240325.xsd (EX-101.SCH) — 3KB
- hchc-20240325_def.xml (EX-101.DEF) — 16KB
- hchc-20240325_lab.xml (EX-101.LAB) — 29KB
- hchc-20240325_pre.xml (EX-101.PRE) — 17KB
- hchc-20240325_htm.xml (XML) — 5KB
01. Other Events
Item 8.01. Other Events. On March 25, 2024, INNOVATE Corp. (the "Company") extended the expiration date of its previously announced $19.0 million common stock rights offering (the "Rights Offering") to 5:00 p.m. Eastern Time on April 9, 2024. This extension will allow stockholders and noteholders who are entitled to participate in the Rights Offering (holders of record of the Company's common stock, Series A-3 Preferred Stock, Series A-4 Preferred Stock and 2026 Convertible Notes as of 5:00 p.m. Eastern Time on March 6, 2024) additional time to participate. A copy of the press release announcing the extension of the Rights Offering is attached hereto as Exhibit 99.1 and incorporated by reference herein. The Rights Offering is being made pursuant to the Company's Registration Statement on Form S-3 (File No. 333-274760) (the "Registration Statement"), filed with the Securities and Exchange Commission (the "SEC") on September 29, 2023, the prospectus forming a part of the Registration Statement and the prospectus supplement relating the Rights Offering filed with the SEC on March 8, 2024.
Forward Looking Statements
Forward Looking Statements This Current Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the rights offering, the timing thereof, the Company's ability to complete the rights offering on the expected terms or at all, and other information and statements that are not historical fact. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. All forward-looking statements speak only as of the date of this Current Report, and unless legally required, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Please refer to the Company's filings with the SEC, including its most recently filed Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, for additional information about the risks and uncertainties related to the Company's business that may affect the forward-looking statements made in this Current Report. Not a Solicitation This Current Report does not constitute an offer to sell or a solicitation of an offer to buy the securities described above, and shall not constitute an offer, solicitation or sale, nor shall there be any sale of such securities of the Company in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 23.1 Press Release dated March 25 , 2024 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 25, 2024 INNOVATE Corp. (Registrant) By: /s/ Michael J. Sena Name: Michael J. Sena Title: Chief Financial Officer